Sponsored by the Memorial Sloan Kettering-Hackensack Meridian Health Partnership
What you need to know
This funding opportunity is for projects with specific aims focusing on mechanisms of resistance or to mitigate toxicity for patients receiving immunotherapy treatment.
Get details of the RFP and the Letter of Intent template by clicking here. After review, a fraction of the LOIs received will be selected for completion of a full application.
The deadline for submission is Friday, September 13 at 11:59 p.m.
Any questions can be directed to: